Pulse Biosciences, Inc.
PLSE
$13.16
-$0.10-0.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 86.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 86.00K | -- | -- | -- | -- |
| Cost of Revenue | 279.00K | -- | -- | -- | -- |
| Gross Profit | -193.00K | -- | -- | -- | -- |
| SG&A Expenses | 8.78M | 8.19M | 7.73M | 9.60M | 5.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.45M | 20.28M | 18.04M | 20.26M | 13.66M |
| Operating Income | -20.37M | -20.28M | -18.04M | -20.26M | -13.66M |
| Income Before Tax | -19.39M | -19.17M | -16.80M | -19.39M | -12.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.39M | -19.17M | -16.80M | -19.39M | -12.68M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.39M | -19.17M | -16.80M | -19.39M | -12.68M |
| EBIT | -20.37M | -20.28M | -18.04M | -20.26M | -13.66M |
| EBITDA | -20.11M | -20.00M | -17.76M | -19.97M | -13.36M |
| EPS Basic | -0.29 | -0.28 | -0.25 | -0.31 | -0.21 |
| Normalized Basic EPS | -0.18 | -0.18 | -0.16 | -0.20 | -0.13 |
| EPS Diluted | -0.29 | -0.28 | -0.25 | -0.31 | -0.21 |
| Normalized Diluted EPS | -0.18 | -0.18 | -0.16 | -0.20 | -0.13 |
| Average Basic Shares Outstanding | 67.39M | 67.28M | 67.13M | 62.06M | 61.07M |
| Average Diluted Shares Outstanding | 67.39M | 67.28M | 67.13M | 62.06M | 61.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |